Clinical results of high-dose-rate I-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer.

被引：0
|
作者：
Kariya, S [1 ]
Yamasaki, I [1 ]
Ogawa, Y [1 ]
Nishioka, A [1 ]
Yoshida, S [1 ]
Ashida, S [1 ]
Inoue, K [1 ]
Shuin, T [1 ]
机构：
[1] Kochi Med Sch, Nankoku, Kochi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：449S / 449S
页数：1
相关论文
共 50 条
  • [1] Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer
    Hiratsuka, J
    Jo, Y
    Yoshida, K
    Nagase, N
    Fujisawa, M
    Imajo, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 684 - 690
  • [2] Clinical results of high-dose-rate Iridium-192 brachy-therapy combined with external beam radiotherapy for localized prostate cancer
    Kariya, Shinji
    Yamasaki, Lchiro
    Ashida, Shingo
    Yokota, Norikazu
    Inoue, Keiji
    Nishioka, Akihito
    Shuin, Taro
    Ogawa, Yasuhiro
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 93 - 93
  • [3] Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer
    Kotecha, Rupesh
    Yamada, Yoshiya
    Pei, Xin
    Kollmeier, Marisa A.
    Cox, Brett
    Cohen, Gil'ad N.
    Zaider, Marco
    Zelefsky, Michael J.
    BRACHYTHERAPY, 2013, 12 (01) : 44 - 49
  • [4] Clinical results of high-close-rate Iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer
    Kariya, S.
    Yamasaki, I.
    Ogawa, Y.
    Nishioka, A.
    Ashida, S.
    Kasahara, K.
    Inoue, K.
    Shuin, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 255 - 255
  • [5] High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
    Yamazaki, Hideya
    Masui, Koji
    Suzuki, Gen
    Aibe, Norihiro
    Shimizu, Daisuke
    Kimoto, Takuya
    Yamada, Kei
    Ueno, Akihisa
    Matsugasumi, Toru
    Yamada, Yasuhiro
    Shiraishi, Takumi
    Fujihara, Atsuko
    Okihara, Koji
    Yoshida, Ken
    Nakamura, Satoaki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
    Hideya Yamazaki
    Koji Masui
    Gen Suzuki
    Norihiro Aibe
    Daisuke Shimizu
    Takuya Kimoto
    Kei Yamada
    Akihisa Ueno
    Toru Matsugasumi
    Yasuhiro Yamada
    Takumi Shiraishi
    Atsuko Fujihara
    Koji Okihara
    Ken Yoshida
    Satoaki Nakamura
    Scientific Reports, 11
  • [7] High-dose-rate brachytherapy combined with external beam radiotherapy for high-risk prostate cancer
    Kariya, S.
    Kobayashi, K.
    Yamasaki, I.
    Ashida, S.
    Tamura, K.
    Inoue, K.
    Shuin, T.
    Yamagami, T.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S950 - S950
  • [8] High-dose-rate Brachytherapy Combined with Hypofractionated External Beam Radiotherapy for Locally Advanced Prostate Cancer
    Ishikawa, H.
    Katoh, H.
    Ebara, T.
    Ando, K.
    Yoshimoto, Y.
    Kawamura, H.
    Okamoto, M.
    Akimoto, T.
    Takahashi, T.
    Nakano, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S189 - S190
  • [9] High-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for intermediate/high risk prostate cancer
    Ishikawa, H.
    Sakurai, H.
    Akimoto, T.
    Ebara, T.
    Okamoto, M.
    Noda, S.
    Katoh, H.
    Yoshida, D.
    Ito, K.
    Nakano, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S307 - S307
  • [10] External beam radiotherapy alone or with high-dose-rate brachytherapy boost for prostate cancer
    Hoskin, P.
    Rojas, A.
    Lowe, G.
    Bryant, L.
    Pandey, G.
    Ostler, P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S107 - S107
12345